S. Garonzik
Antimicrobial Agents and Chemotherapy · 2011
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Who trusts S. Garonzik overall
Papers from S. Garonzik's perspective
Ordered by how strongly the researchers S. Garonzik trusts endorse each paper. Same corpus, a different order for every researcher.
- Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
- Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. (Clinical Infectious Diseases)
- Ways to Fit a PK Model with Some Data Below the Quantification Limit (Journal of Pharmacokinetics and Pharmacodynamics)
- Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. (Lancet. Infectious Diseases (Print))
- Acinetobacter infection. (New England Journal of Medicine)
- Trends in antimicrobial drug development: implications for the future. (Clinical Infectious Diseases)
- Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. (Clinical Infectious Diseases)
- Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. (Journal of Infectious Diseases)
- Global Challenge of Multidrug-Resistant Acinetobacter baumannii (Antimicrobial Agents and Chemotherapy)
- Linezolid resistance in a clinical isolate of Staphylococcus aureus. (The Lancet)